Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
NCT00157976
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
660
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
Photrex (rostaporfin)
Sponsor
Miravant Pharmaceuticals